期刊文献+

他汀类药物的血压调节作用 被引量:10

Blood pressure regulation of statins
下载PDF
导出
摘要 他汀类药物是治疗高胆固醇血症的首选药物 ,临床已广泛应用于血脂异常的治疗。近年来 ,临床研究发现他汀类药物可改善高血压合并血脂异常患者的血压 ,这种作用不仅见于未经治疗的高血压患者 ,对于已经使用抗高血压药物治疗的高血压患者也有一定的疗效。但有一些研究并不完全肯定这一作用。他汀类药物降低血压的作用在很大程度上不依赖于其调脂作用 ,可能与其改善血管内皮功能及调节血管紧张素受体有关。 Statins is first choice of hypercholesteroiemia. Recently, clinical investigations have shown that statins can correct blood pressure in hypertension patients accompanied with lipid abnormalities. This result can be observed not only in untreated patients but also in patients treated with antihypertensive drugs. But some researches did not support this result completely. To some extend, the mechanisms responsible for the hypotensive effect seem to be largely independent on the effect of statins on lipid profile, and may be related to the improvement of endothelial function and the regulation of angiotensin II receptors.
出处 《中国临床药理学与治疗学》 CAS CSCD 2004年第4期374-377,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 他汀类药物 高血压 血脂异常 内皮功能 血管紧张素受体 statins hypertension plasma lipid abnormalities endothelial function angiotensin II receptors
  • 相关文献

参考文献29

  • 1[1]Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M.Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction[J]. N Engl J Med, 1998; 339(4) :229- 34
  • 2[2]Poulter N. Coronary heart disease is a multifactorial disease[J].Am J Hypertens, 1999; 12(10pt2) :92 - 5S
  • 3[3]Lloyd-Jones DM, Evans JC, Larson MG, O' Donnell CJ, Wilson PW, Levy D. Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study[J]. Arch Intern Med, 1999; 159(18) :2206- 12
  • 4[4]Thomas F, Bean K, Guize L, Quentzel S, Argyriadis P, Benetos A. Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young ( < 55 years)men and women[J]. Eur Heart J ,2002;23(7) :528 - 35
  • 5[5]Sung BH, Izzo JL, Wilson MF. Effects of cholesterol reduction on BP response to mental stress in patients with high cholesterol[J]. Am J Hypertens, 1997; 10(6) :592- 9
  • 6[6]Stern N, Grosskopf I, Shapira I, Kisch E, Isaacov A, Limor R, et al. Risk factor clustering in hypertensive patients: impact of the reports of NCEP-II and second joint task force on coronary prevention on JNC-VI guidelines[J]. J Intern Med, 2000; 248(3) :203 - 10
  • 7[7]Vaughan C J, Gotto AM, Basson CT. The evolving role of statins in the management of atherosclerosis[J]. J Am Coll Cardiol,2000;35(1):1 - 10
  • 8[8]Maron DJ, Fazio S, Linton, Mac RF. Current perspectives on statin[J]. Circulation, 2000; 101(2) :207 - 13
  • 9[9]Goode GK, Miller JP, Heagerty AM. Hyperlipidaemia, hypertension, and coronary heart disease[J]. Lancet, 1995; 345(8946) :362 - 4
  • 10[10]Straznicky NE, Howes LG, Lam W, Louis WJ. Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension[J]. Am J Cardiol, 1995;75(8) :582 - 6

同被引文献136

引证文献10

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部